Concepedia

Maju Mathews

MM

39

Publications

1.1K

Citations

20

H-Index

2005

Active since

Affiliations

Janssen (United States)(Current)

Janssen Scientific Affairs (United States)

Allergan (United States)

Janssen (Belgium)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Maju Mathews is an author at Janssen (United States) specializing in medicine, psychiatry, and psychopathology.

ORCID

Top concepts

Publications per year

2005–2023

39

Publications

39

Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder

Robert L. Findling, Ronald L. Landbloom, Armin Szegedi et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2015 · 100 citations · Full text

Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder

Maju Mathews, Carl Gommoll, Dalei Chen et al. · International Clinical Psychopharmacology · 2014 · 76 citations · Full text

, , +15

Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder

Armin Szegedi, Suresh Durgam, Mary Mackle et al. · American Journal of Psychiatry · 2017 · 66 citations · Full text

<p>Patients’ Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire</p>

Clifton Blackwood, Panna Sanga, Isaac Nuamah et al. · Patient Preference and Adherence · 2020 · 62 citations · Full text

Efficacy and Safety of Vilazodone in Major Depressive Disorder

Harry A. Croft, Nunzio Pomara, Carl Gommoll et al. · The Journal of Clinical Psychiatry · 2014 · 61 citations · Full text

Rows per page

1–5 of 39